vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and IPG PHOTONICS CORP (IPGP). Click either name above to swap in a different company.
IPG PHOTONICS CORP is the larger business by last-quarter revenue ($274.5M vs $185.2M, roughly 1.5× AMICUS THERAPEUTICS, INC.). IPG PHOTONICS CORP runs the higher net margin — 4.8% vs 0.9%, a 3.9% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 17.1%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $10.9M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 4.4%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
FOLD vs IPGP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $274.5M |
| Net Profit | $1.7M | $13.3M |
| Gross Margin | 85.7% | 36.1% |
| Operating Margin | 8.6% | 1.2% |
| Net Margin | 0.9% | 4.8% |
| Revenue YoY | 23.7% | 17.1% |
| Net Profit YoY | -88.5% | 69.8% |
| EPS (diluted) | $0.00 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $274.5M | ||
| Q3 25 | $169.1M | $250.8M | ||
| Q2 25 | $154.7M | $250.7M | ||
| Q1 25 | $125.2M | $227.8M | ||
| Q4 24 | $149.7M | $234.3M | ||
| Q3 24 | $141.5M | $233.1M | ||
| Q2 24 | $126.7M | $257.6M | ||
| Q1 24 | $110.4M | $252.0M |
| Q4 25 | $1.7M | $13.3M | ||
| Q3 25 | $17.3M | $7.5M | ||
| Q2 25 | $-24.4M | $6.6M | ||
| Q1 25 | $-21.7M | $3.8M | ||
| Q4 24 | $14.7M | $7.8M | ||
| Q3 24 | $-6.7M | $-233.6M | ||
| Q2 24 | $-15.7M | $20.2M | ||
| Q1 24 | $-48.4M | $24.1M |
| Q4 25 | 85.7% | 36.1% | ||
| Q3 25 | 88.5% | 39.5% | ||
| Q2 25 | 90.2% | 37.3% | ||
| Q1 25 | 90.7% | 39.4% | ||
| Q4 24 | 90.1% | 38.6% | ||
| Q3 24 | 90.6% | 23.2% | ||
| Q2 24 | 91.1% | 37.3% | ||
| Q1 24 | 87.7% | 38.7% |
| Q4 25 | 8.6% | 1.2% | ||
| Q3 25 | 20.3% | 3.1% | ||
| Q2 25 | -6.1% | 0.0% | ||
| Q1 25 | -6.3% | 0.8% | ||
| Q4 24 | 10.7% | 6.0% | ||
| Q3 24 | 15.3% | -108.7% | ||
| Q2 24 | 11.8% | 4.7% | ||
| Q1 24 | -25.1% | 7.6% |
| Q4 25 | 0.9% | 4.8% | ||
| Q3 25 | 10.2% | 3.0% | ||
| Q2 25 | -15.8% | 2.6% | ||
| Q1 25 | -17.3% | 1.6% | ||
| Q4 24 | 9.8% | 3.3% | ||
| Q3 24 | -4.8% | -100.2% | ||
| Q2 24 | -12.4% | 7.8% | ||
| Q1 24 | -43.9% | 9.6% |
| Q4 25 | $0.00 | $0.30 | ||
| Q3 25 | $0.06 | $0.18 | ||
| Q2 25 | $-0.08 | $0.16 | ||
| Q1 25 | $-0.07 | $0.09 | ||
| Q4 24 | $0.05 | $0.27 | ||
| Q3 24 | $-0.02 | $-5.33 | ||
| Q2 24 | $-0.05 | $0.45 | ||
| Q1 24 | $-0.16 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $839.3M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $2.1B |
| Total Assets | $949.9M | $2.4B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $839.3M | ||
| Q3 25 | $263.8M | $870.4M | ||
| Q2 25 | $231.0M | $899.6M | ||
| Q1 25 | $250.6M | $926.9M | ||
| Q4 24 | $249.9M | $930.2M | ||
| Q3 24 | $249.8M | $1.0B | ||
| Q2 24 | $260.1M | $1.1B | ||
| Q1 24 | $239.6M | $1.1B |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $2.1B | ||
| Q3 25 | $230.4M | $2.1B | ||
| Q2 25 | $204.3M | $2.1B | ||
| Q1 25 | $193.6M | $2.1B | ||
| Q4 24 | $194.0M | $2.0B | ||
| Q3 24 | $178.8M | $2.1B | ||
| Q2 24 | $132.5M | $2.3B | ||
| Q1 24 | $130.7M | $2.3B |
| Q4 25 | $949.9M | $2.4B | ||
| Q3 25 | $868.8M | $2.4B | ||
| Q2 25 | $815.3M | $2.4B | ||
| Q1 25 | $789.8M | $2.3B | ||
| Q4 24 | $785.0M | $2.3B | ||
| Q3 24 | $786.6M | $2.4B | ||
| Q2 24 | $749.5M | $2.5B | ||
| Q1 24 | $721.8M | $2.6B |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $28.8M |
| Free Cash FlowOCF − Capex | $16.0M | $10.9M |
| FCF MarginFCF / Revenue | 8.6% | 4.0% |
| Capex IntensityCapex / Revenue | 0.2% | 6.5% |
| Cash ConversionOCF / Net Profit | 9.62× | 2.17× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $-3.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $28.8M | ||
| Q3 25 | $35.7M | $35.3M | ||
| Q2 25 | $-26.5M | $-2.2M | ||
| Q1 25 | $7.8M | $13.4M | ||
| Q4 24 | $-3.9M | $73.8M | ||
| Q3 24 | $-23.0M | $66.1M | ||
| Q2 24 | $22.7M | $53.5M | ||
| Q1 24 | $-29.7M | $54.6M |
| Q4 25 | $16.0M | $10.9M | ||
| Q3 25 | $35.3M | $14.6M | ||
| Q2 25 | $-28.9M | $-17.6M | ||
| Q1 25 | $7.5M | $-11.4M | ||
| Q4 24 | $-4.2M | $50.6M | ||
| Q3 24 | $-23.3M | $43.0M | ||
| Q2 24 | $21.6M | $29.2M | ||
| Q1 24 | $-31.5M | $26.5M |
| Q4 25 | 8.6% | 4.0% | ||
| Q3 25 | 20.9% | 5.8% | ||
| Q2 25 | -18.7% | -7.0% | ||
| Q1 25 | 6.0% | -5.0% | ||
| Q4 24 | -2.8% | 21.6% | ||
| Q3 24 | -16.5% | 18.4% | ||
| Q2 24 | 17.0% | 11.3% | ||
| Q1 24 | -28.5% | 10.5% |
| Q4 25 | 0.2% | 6.5% | ||
| Q3 25 | 0.2% | 8.3% | ||
| Q2 25 | 1.6% | 6.1% | ||
| Q1 25 | 0.2% | 10.9% | ||
| Q4 24 | 0.2% | 9.9% | ||
| Q3 24 | 0.3% | 9.9% | ||
| Q2 24 | 0.9% | 9.4% | ||
| Q1 24 | 1.6% | 11.1% |
| Q4 25 | 9.62× | 2.17× | ||
| Q3 25 | 2.06× | 4.73× | ||
| Q2 25 | — | -0.34× | ||
| Q1 25 | — | 3.58× | ||
| Q4 24 | -0.27× | 9.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.65× | ||
| Q1 24 | — | 2.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
IPGP
| Materials Processing | $232.8M | 85% |
| Laser And Non Laser Systems | $38.8M | 14% |
| Transferred Over Time | $5.3M | 2% |
